Reuters logo
BRIEF-Chembio Diagnostics says CEO John Sperzel taking medical leave of absence
May 31, 2017 / 10:12 AM / 6 months ago

BRIEF-Chembio Diagnostics says CEO John Sperzel taking medical leave of absence

May 31 (Reuters) - Chembio Diagnostics Inc:

* Says CEO John Sperzel is taking a medical leave of absence

* Chembio Diagnostics Inc says co's board appointed Sharon Klugewicz, president Americas region, and former coo as acting chief executive officer Source text (bit.ly/2rDUtFI) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below